UHS · NYSE · STOCK
Universal Health Services (UHS) Stock Analysis
$187.51
52W $140.08 – $246.33
66/100
$10.83B
7.3
1.03
Is UHS Bullish or Bearish?
Bullish.
Innellis AI committee rates Universal Health Services (UHS) Buy with a composite score of 66/100
, based on 6 analysts with 83% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +9.06 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -10.94 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 29.4% yoy. Portfolio Manager remains cautious — 2 existing position pair(s) are highly correlated already. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- P/E of 6.9 is inexpensive for the broad market — Value
- ROE of 20.8% shows genuine earnings power backing the valuation — Value
- EPS growing 29.4% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- News sentiment is positive (+0.20 across 10 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
66/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 2%
of 192 Healthcare peers
Value Analyst
bullish
70
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 6.9 is inexpensive for the broad market
Growth Analyst
bullish
78
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 29.4% YoY
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bullish
70
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 10 articles, 14d)
Portfolio Manager
bearish
35
/ 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score moved marginally from 68.4 to 65.9.
- Bullish support removed: 2 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- Portfolio Manager: score 30->35 (+5).
- Value Analyst: +1 bullish signal(s).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
77.4
Overbought
MACD Histogram
0.431
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$140.14
Resistance
$243.66
Bollinger %B
1.24
Above Upper Band
Price vs Moving Averages
EMA 9
$178.98
Above
EMA 21
$177.26
Above
EMA 50
$173.62
Above
EMA 200
$175.94
Above
Fundamental Analysis
Valuation
100
Growth
63
Profitability
84
Financial Health
58
Cash Flow
70
Valuation
P/E Ratio
7.3×
P/B Ratio
1.42×
PEG Ratio
0.26
Dividend Yield
0.45%
52W High
$246.33
52W Low
$140.08
Quality & Growth
ROE
2046.2%
ROA
933.0%
Gross Margin
9068.6%
Operating Margin
1136.4%
Revenue Growth YoY
—
Debt / Equity
0.70
AI Fundamental Assessment
P/E ratio of 7.3 (inexpensive relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 0.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 20.5%; Return on assets of 9.3%; Net margin of 8.4%; Gross margin of 90.7%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 0.70; Free cash flow per share is positive (13.86); Most recent quarter missed estimates by 0.6%; EPS growth accelerating (-4.4% -> +6.4% QoQ); Average YoY EPS growth of 11.8%; Analyst estimates flat over recent quarters
Get the Full UHS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →